Publications in collaboration with researchers from Clínica Universitaria de Navarra (19)

2024

  1. Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial

    Archivos de Bronconeumologia, Vol. 60, Núm. 7, pp. 417-422

2023

  1. Metallomic Signatures of Lung Cancer and Chronic Obstructive Pulmonary Disease

    International Journal of Molecular Sciences, Vol. 24, Núm. 18

2018

  1. Comparison of the 2017 and 2015 global initiative for chronic obstructive lung disease reports impact on grouping and outcomes

    American Journal of Respiratory and Critical Care Medicine, Vol. 197, Núm. 4, pp. 463-469

  2. The importance of symptoms in the longitudinal variability of clusters in COPD patients: A validation study

    Respirology, Vol. 23, Núm. 5, pp. 485-491

2017

  1. Erratum: Telomere shortening and accelerated aging in COPD: Findings from the BODE cohort [Respiratory Research. 59, 1, (2017)(18)] DOI: 10.1186/s12931-017-0547-4

    Respiratory Research

2016

  1. Agreement between a simple dyspnea-guided treatment algorithm for stable COPD and the GOLD guidelines: A pilot study

    International Journal of COPD, Vol. 11, Núm. 1, pp. 1217-1222

  2. Role of HIF1A, VEGFA and VEGFR2 SNPs in the susceptibility and progression of COPD in a Spanish population

    PLoS ONE, Vol. 11, Núm. 5

2015

  1. COPD comorbidities network

    European Respiratory Journal, Vol. 46, Núm. 3, pp. 640-650

2014

  1. Erratum: New GOLD classification: Longitudinal data on group assignment [Respir Res. 15, (2014) 3, 10.1186/1465-9921-15-3]

    Respiratory Research

2012

  1. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease

    American Journal of Respiratory and Critical Care Medicine, Vol. 186, Núm. 2, pp. 155-161

2011

  1. The 6-min walk distance in healthy subjects: Reference standards from seven countries

    European Respiratory Journal, Vol. 37, Núm. 1, pp. 150-156

  2. The progression of chronic obstructive pulmonary disease is heterogeneous: The experience of the BODE cohort

    American Journal of Respiratory and Critical Care Medicine, Vol. 184, Núm. 9, pp. 1015-1021

2010

  1. EPOC en la mujer

    Archivos de Bronconeumologia, Vol. 46, Núm. SUPPL. 3, pp. 23-27

  2. EPOC: inflamación bronquial y sistémica

    Archivos de Bronconeumologia, Vol. 46, Núm. SUPPL. 4, pp. 9-15

  3. Microalbuminuria and hypoxemia in patients with chronic obstructive pulmonary disease

    American Journal of Respiratory and Critical Care Medicine, Vol. 182, Núm. 8, pp. 1004-1010

2009

  1. EPOC y malnutrición

    Archivos de Bronconeumologia, Vol. 45, Núm. SUPPL.5, pp. 31-35

  2. Enfermedad pulmonar obstructiva crónica: ¿qué hay más allá del índice BODE?

    Archivos de Bronconeumología, Vol. 45, pp. 35-39

  3. Sex differences in mortality in patients with COPD

    European Respiratory Journal, Vol. 33, Núm. 3, pp. 528-535

2007

  1. Systemic involvement and prognostic factors

    Archivos de Bronconeumologia, Vol. 43, Núm. SUPPL. 3, pp. 25-34